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Abstract
Background: Absence of interlobar collateral ventilation us-
ing the Chartis measurement is the key predictor for success-
ful endobronchial valve treatment in severe emphysema. 
Chartis was originally validated in spontaneous breathing 
patients under conscious sedation (CS); however, this can be 
challenging due to cough, mucus secretion, mucosal swell-
ing, and bronchoconstriction. Performing Chartis under 
general anesthesia (GA) avoids these problems and may re-
sult in an easier procedure with a higher success rate. How-
ever, using Chartis under GA with positive pressure ventila-
tion has not been validated. Objectives: In this study we in-
vestigated the impact of anesthesia technique, CS versus GA, 
on the feasibility and outcomes of Chartis measurement. 
Methods: We retrospectively analyzed all Chartis measure-
ments performed at our hospital from October 2010 until 
December 2017. Results: We analyzed 250 emphysema pa-
tients (median forced expiratory volume in 1 s 26%, range 
12–52% predicted). In 121 patients (48%) the measurement 
was performed using CS, in 124 (50%) using GA, and in 5 (2%) 
both anesthesia techniques were used. In total, 746 Chartis 
readings were analyzed (432 CS, 277 GA, and 37 combina-
tion). Testing under CS took significantly longer than GA 
(median 19 min [range 5—65] vs. 11 min [3–35], p < 0.001) 
and required more measurements (3 [1–13] vs. 2 [1–6], p < 
0.001). There was no significant difference in target lobe vol-
ume reduction after treatment (–1,123 mL [–3,604 to 332] in 
CS vs. –1,251 mL [–3,333 to –1] in GA, p = 0.35). Conclusions: 
In conclusion, Chartis measurement under CS took signifi-
cantly longer and required more measurements than under 
GA, without a difference in treatment outcome. We recom-
mend a prospective trial comparing both techniques within 
the same patients to validate this approach.
© 2018 The Author(s) 
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Bronchoscopic lung volume reduction using endo-
bronchial one-way valves (EBV) has been shown to be 
clinically effective and to have an acceptable safety profile 
in selected patients with severe emphysema [1–5]. Maxi-
mal clinical improvement after EBV treatment is associ-
ated with complete lobar atelectasis [1, 2, 6–8]. However, 
lobar atelectasis will not be achieved in the presence of 
interlobar collateral ventilation due to an incomplete in-
terlobar fissure. In approximately 60% of the patients 
with severe emphysema, the interlobar fissure is not com-
plete [9]. Interlobar collateral ventilation can be mea-
sured using the Chartis System® (Pulmonx Inc., Red-
wood City, CA, USA). 
The Chartis system was originally validated in patients 
using conscious sedation [8, 10]. However, in clinical 
practice the Chartis measurement is also often performed 
using general anesthesia for practical reasons. Under con-
scious sedation, measurements are often challenging to 
perform or even fail, due to increased coughing, mucus 
secretion, bronchoconstriction, swelling of mucosa, and 
difficulty to maintain an optimal level of sedation. There-
fore, general anesthesia was recently suggested to be the 
preferred and recommended technique for both the Char-
tis measurement and the subsequent EBV placement due 
to the ease of airway and patient management [11].
To our knowledge, effects of conscious sedation and 
general anesthesia on the Chartis measurement have nev-
er been compared in the literature. The objective of this 
study was to investigate the impact of anesthesia tech-
nique, conscious sedation versus general anesthesia, on 
both the feasibility of the Chartis measurement and the 
outcome of subsequent EBV placement.
Methods
Study Design and Population
Retrospectively, we analyzed data of all patients who under-
went a Chartis measurement at the University Medical Center 
Groningen, the Netherlands. From October 2010 until December 
2017, we performed Chartis measurements in 250 patients in dif-
ferent trials (“Chartis trial” [8], “STELVIO trial” [1], “IMPACT 
trial” [4], “TRANSFORM trial” [5], “BREATHE-NL registry” 
[NCT02815683]) and in patients treated in a compassionate use 
setting (Table 1). All trials had prior approval from the local ethics 
committee and all patients provided informed consent. 
Anesthesia Technique
Conscious sedation is a drug-induced state of reduced con-
sciousness during which patients are able to purposefully respond 
to verbal commands or light tactile stimuli and are able to maintain 
oxygenation and airway control without intervention [12]. Con-
scious sedation was induced with intravenous propofol and remi-
fentanil. Medication dosage was titrated up to a level where pa-
tients were adequately sedated but still arousable and breathing 
spontaneously. In addition, a 1% w/v lidocaine spray was applied 
locally to the upper and lower airways.
General anesthesia is a drug-induced loss of consciousness dur-
ing which patients are not arousable, even by painful stimulation, 
spontaneous ventilation cannot be maintained, and an artificial 
maintenance of open airway is necessary [12]. General anesthesia 
was induced through administration of intravenous propofol and 
remifentanil and muscle relaxation was achieved with rocuronium 
bromide. Patients were intubated with a flexible 9-mm endotra-
cheal tube and positive pressure ventilation was applied with target 
settings of low ventilation frequency (8–10×/min), long expiratory 
settings (inspiratory/expiratory ratio of 1: 3), and positive end-ex-
piratory pressure of 3 cm H2O [11].
Chartis Measurement
Collateral ventilation measurements were performed using the 
Chartis System® (Pulmonx Inc., Redwood City, CA, USA). The 
Chartis system consists of a catheter, with an inflatable balloon at 
the tip, which can be advanced through the 2.8-mm or larger work-
ing channel of a bronchoscope (Fig. 1). Inflation of the balloon al-
lows for temporary occlusion of the airway, during which airflow 
coming from the occluded lobe can be assessed [13]. Expired air-
flow volume, pressure, and resistance measurements are analyzed 
and visualized by the Chartis console. Distinctive airflow patterns 
allow for assessment of collateral ventilation status (Fig. 2) [9]. 
Outcome Variables
We analyzed the Chartis measurements that were performed in 
the predetermined treatment target and ipsilateral lobes. Our pri-
mary outcome was the total duration of Chartis measurement, de-
fined as the total duration of all measurement attempts combined. 
Secondary outcomes were the number of Chartis measurements 
performed per patient, number of measurements per lobe, number 
of lobes measured, expired airflow volume measured with Chartis, 
target lobe volume reduction (TLVR) after treatment, and Chartis 
outcome category. The Chartis outcome was categorized by the 
treating physician in 4 different categories: (1) negative collateral 
ventilation, (2) positive collateral ventilation, (3) undetermined 






Chartis [8], 2013 29 (24) 1 (1) 0
STELVIO [1], 2015 80 (66) 0 (0) 4 (80)
IMPACT [4], 2016 5 (4) 20 (16) 1 (20)
TRANSFORM [5], 2017 0 (0) 15 (12) 0
BREATHE-NL 0 (0) 75 (60) 0
Compassionate use 7 (6) 13 (11) 0
Total 121 (100) 124 (100) 5 (100)
Data is presented as number of cases (percentage of total cases).
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measurement (signal output but not possible to determine collat-
eral ventilation status, caused for example by touching of the bron-
chial wall by the Chartis catheter tip, secretion occlusion of the 
catheter leading to low/no flow, or measurement distortion by 
coughing and patient exhaling during exertion), and (4) discarded 
measurement (not possible to obtain valid signal output due to loss 
of balloon seal and total catheter blockage due to excessive mucus).
TLVR was calculated using different quantitative high-resolu-
tion computed tomography software per study protocol. Scans 
were analyzed using Thirona LungQ (Nijmegen, The Netherlands) 
(STELVIO, BREATHE-NL registry, and compassionate use), 
VIDA Diagnostics software (Coralville, IA, USA) (TRANSFORM 
and IMPACT), or MedQia software (Los Angeles, CA, USA) 
(CHARTIS).
Statistical Analysis
To compare differences in patient characteristics, measure-
ments duration, number of Chartis measurements, number of 
measurements per lobe, number of lobes measured, expired air-
flow volume, and TLVR between conscious sedation and general 
anesthesia, an independent-samples t test was performed in case 
of normal distribution of data and a Mann-Whitney U test in case 
of non-normal distribution. p values below 0.05 were considered 
statistically significant. All statistical analyses were performed us-
ing SPSS version 22 (IBM, New York, NY, USA).
Results
Of the 250 included patients, 121 patients (48%) un-
derwent conscious sedation and 124 patients (50%) un-
derwent general anesthesia. Five patients (2%) received 
both anesthesia techniques after conversion from con-
scious sedation to general anesthesia; these were not used 
a b
c d
Fig. 1. Chartis system® (Pulmonx Inc., Redwood City, CA, USA). a Console with catheter. b Catheter with in-
flated balloon at tip. c Bronchoscopic view of inflated balloon at catheter tip in airway. d Bronchoscopic view 















in the analyses (see Fig. 3 for patient flowchart; patient 
characteristics are shown in Table 2). No direct anesthe-
sia-related complications were observed in either group. 
The Chartis measurement outcomes per anesthesia 
technique are provided in Table 3. Chartis measurement 
under conscious sedation took significantly (p < 0.001) 
longer than under general anesthesia (median 19 min 
[range 5–65] vs. 11 min [3–35]), required a significantly 
(p < 0.001) higher number of measurements (3 [1–13] vs. 
2 [1–6]), and required a significantly (p < 0.001) higher 
number of measurements per lobe (2 [1–7] vs. 1 [1–3]). 
The proportions of undetermined and discarded mea-
surements and the number of lobes measured per patient 
were not significantly different between the groups (p > 
0.05).
Median TLVR in the conscious sedation group was 
–1,123 mL (–3,604 to 332) (relative TLVR 72%) com-
pared to –1,251 mL (–3,333 to –1) (relative TLVR 77%) 
in the general anesthesia group. Differences in both abso-
lute as well as relative TLVR were not significant between 
anesthesia techniques.
In total, 746 Chartis measurements (432 conscious se-
dation, 277 general anesthesia, and 37 combination) were 









Fig. 2. Chartis measurement reports for the 4 different categories. a Negative collateral ventilation (CV) under 
conscious sedation. b Negative CV under general anesthesia. c Positive CV under conscious sedation. d Positive 























Fig. 3. Patient flowchart. Patients who received both conscious se-
dation and general anesthesia were not included in the analysis. 
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lobes, of which 373 were categorized as negative collat-
eral ventilation, 151 positive collateral ventilation, 125 
were undetermined, and 97 were discarded measure-
ments. Under conscious sedation, the Chartis catheter 
balloon ruptured 3 times compared to once under gen-
eral anesthesia. 
In patients with absence of collateral ventilation, the 
expired airflow volume was significantly (p = 0.015) high-
Table 2. Patient characteristics 
Characteristics Conscious sedation General anesthesia Combination
n 121 124 5
Female/male, % 60/40 68/32 80/20
Age, years 60 (36–78) 62 (42–78) 54 (47–68)
BMI 23.8 (17–37) 23.2 (16-35) 22.6 (20–26)
Pack-years, years* 35 (0–110) 39 (8–148) 35 (18–60)
FEV1, % predicted* 27.0 (12–52) 25.8 (12–48) 26.0 (23–32)
RV, % predicted* 216.0 (120–361) 232.5 (130–484) 245.0 (182–263)
6MWD, m* 361.3±95.4 316.6±100.3 411.8±72.7
SGRQ total score, units 60.3±12.8 60.0±11.3 56.1±8.1
Target lobe volume, mL 1,747 (780–4,666) 1,632 (956–3,755) 2,146 (1,067–2,746)
Data is presented as mean ± standard deviation in case of normal distribution of data and as median (range) in case of non-normal 
distribution. BMI, Body mass index; FEV1, forced expiratory volume in 1 s; RV, residual volume; 6MWD, 6-minute walking distance; 
SGRQ, St. George’s Respiratory Questionnaire. Difference between conscious sedation and general anesthesia was analyzed with an 
independent-samples t test in case of normal distribution of data and a Mann-Whitney U test in case of non-normal distribution. * p < 
0.05 between conscious sedation and general anesthesia.
Table 3. Chartis measurement outcomes under conscious sedation and general anesthesia





Duration of total Chartis procedure per patient, s –1,140 (300 to 3,900) 656 (180 to 2,100) 484 <0.001
Sum of measurement duration per patient, excluding discarded measurements, s 668 (103 to 2,109) 398 (61 to 1,211) 270 <0.001
Sum of measurement duration per patient, in measurements with CV-negative 
outcome, s 356 (95 to 1,469) 308 (65 to 875) 48 0.02
Number of measurements
Number of measurements per patient 3 (1 to 13) 2 (1 to 6) 1 <0.001
Number of measurements per patient, excluding discarded and undetermined 
measurements 2 (0 to 13) 1 (0 to 4) 1 <0.001
Number of discarded measurements, total number in group (percentage of total 
measurements) 49 (11%) 39 (14%) NA 0.97
Number of undetermined measurements, total number in group (percentage of total 
measurements) 67 (16%) 43 (16%) NA 0.22
Measurements per lobe, including discarded and undetermined measurements 2 (1 to 7) 1 (1 to 3) 1 <0.001
Measured lobes per patient, including discarded and undetermined measurements 2 (1 to 4) 2 (1 to 4) 0 0.32
Analyzed airflow volume
Expired airflow volume per patient, mL 903 (19 to 6,719) 462 (34 to 7,639) 441 <0.001
Expired airflow volume per patient in measurements with CV-negative outcome, mL 490 (6 to 2,504) 390 (34 to 1,561) 100 0.015
Target lobe volume reduction
Target lobe volume reduction per patient, mL –1,123 (–3,604 to 332) –1,251 (–3,333 to –1) 128 0.35
Target lobe volume reduction per patient, % 72 (100 to 24) 77 (100 to 0) 5 0.27
Data are presented as mean ± standard deviation in case of normal distribution of data and as median (range) in case of non-normal distribution. In case 
of categorical variables, data is presented as n (%). Difference between conscious sedation and general anesthesia was analyzed with an independent-samples 
t test in case of normal distribution of data and a Mann-Whitney U test in case of non-normal distribution. CV, collateral ventilation.
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er under conscious sedation than under general anesthe-
sia (490 mL [range: 6–2,504] vs. 390 mL [range: 34–
1,561]).
Discussion
To our knowledge, this is the first study comparing 
conscious sedation and general anesthesia during bron-
choscopic evaluation of interlobar collateral ventilation 
with Chartis in patients with severe emphysema. The 
Chartis testing under conscious sedation took signifi-
cantly longer and required a higher number of measure-
ments in total and per lobe than general anesthesia, indi-
cating the ease of use of Chartis under general anesthesia. 
In the EBV-treated patients, after a collateral ventilation-
negative Chartis measurement, no significant differences 
in TLVR were found between the conscious sedation and 
general anesthesia groups, suggesting no inferiority of the 
diagnostic value of Chartis under general anesthesia.
The observed differences in duration and number of 
measurements could be the result of more frequent pres-
ence of mucus, coughing, bronchus constriction, airway 
wall edema, and sedation problems, causing catheter ob-
struction in the conscious sedation group, leading to 
more complex procedures and more difficult interpreta-
tion of Chartis results.
There are no studies reported that compared various 
techniques of anesthesia with respect to feasibility. A 
study by Gesierich et al. [14] compared airway collapse 
during Chartis measurement under spontaneous breath-
ing and jet ventilation and recommended to use sponta-
neous breathing to prevent airway collapse. In the pa-
tients who received general anesthesia in our study, posi-
tive pressure ventilation via an endotracheal tube was 
applied. 
Recently, a best practice recommendations panel on 
endoscopic lung volume reduction favored the use of 
general anesthesia for Chartis measurement and the sub-
sequent EBV placement due to the ease of use and airway 
and patient management [11]. 
Five patients received both conscious sedation as well 
as general anesthesia. These patients were converted from 
conscious sedation to general anesthesia because the 
treating physician was unable to perform a valid measure-
ment under conscious sedation, due to mucus presence, 
patient unrest, coughing, and low flow. The fact that in 
some patients, measurement was only possible in a gen-
eral anesthesia setting might already indicate the better 
feasibility of this approach.
Arguments against the use of general anesthesia for 
Chartis measurement could be the higher dosage of med-
ication received, compared to conscious sedation, as well 
as the intubation and ventilation of severe emphysema pa-
tients. Higher cost of the application of general anesthesia 
should be considered, especially in limited resource set-
tings. On the other hand, the EBV procedure is much eas-
ier and faster to perform under general anesthesia. Fur-
thermore, at our hospital, patients are always scheduled 
for a combined Chartis measurement with a subsequent 
EBV procedure (and never for a diagnostic Chartis proce-
dure alone to avoid an unnecessary additional bronchos-
copy), making the use of general anesthesia for the Chartis 
procedure more practical. In addition, no anesthesia-re-
lated adverse events were reported in our patients. The use 
of both conscious sedation as well as general anesthesia is 
deemed safe in interventional pulmonology [15]. 
No significant differences in TLVR after treatment be-
tween the conscious sedation and general anesthesia 
groups were found. This is an important finding since the 
Chartis measurement was not yet validated under gen-
eral anesthesia. The absence of collateral ventilation in 
combination with successful EBV placement, resulting in 
sufficient TLVR, is the driver for treatment success as 
TLVR is a predictor for clinically meaningful change after 
treatment [16, 17].
A higher percentage of positive collateral ventilation 
measurements was found in the conscious sedation tech-
nique. One explanation could be the improved patient 
selection over time by quantitative high-resolution com-
puted tomography (fissure) analysis, which decreased the 
number of patients with positive collateral ventilation 
outcomes in Chartis measurement in the trials. In addi-
tion, the objective of the CHARTIS study, in which al-
most all patients underwent conscious sedation, was to 
determine whether Chartis assessment of collateral ven-
tilation could predict significant TLVR after EBV place-
ment, actively including patients with both negative as 
well as positive collateral ventilation status [8].
Baseline characteristics were significantly different for 
forced expiratory volume in 1 s, residual volume, and 
6-minute walking distance, with the more severe patients 
being in the general anesthesia group. This difference can 
be explained by the fact that general anesthesia was more 
frequently applied in later trials, which were open to in-
clusion of patients with more severe disease. We do not 
believe that the severity of emphysema influenced Chartis 
measurement outcomes, especially because (non-)intact 
fissures are probably not caused by emphysematous dis-
ease, but rather reflect an inherited trait [18]. 
Chartis Measurement: Conscious 
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The expired total airflow volume in patients with neg-
ative collateral ventilation was significantly higher under 
conscious sedation than under general anesthesia. This is 
an interesting finding, since we assumed that patients un-
der conscious sedation with spontaneous breathing 
would rely on the elasticity of the lobe to exhale through 
the catheter, while patients under general anesthesia 
would have both elasticity as well as driving force from 
positive pressure in the adjacent lobe(s). Another possible 
explanation could be that due to an easier procedure un-
der general anesthesia, the sampling time was shorter 
leading to a lower amount of analyzed airflow volume. 
The observed difference did not lead to a difference in 
diagnostic outcome.
A limitation of our trial is that most Chartis measure-
ments under conscious sedation were carried out in the 
earlier studies, while at that point, Chartis measurement 
performance experience was limited, possibly leading to 
a learning curve bias. A study by Herzog et al. [19], for 
example, described a 12% reduction of inconclusive 
Chartis measurements, due to increasing experience of 
the bronchoscopists, in a 5-year period. Another limita-
tion of our study is that patients were retrospectively in-
cluded from several trials, introducing a possible selec-
tion bias. On the other hand, we sequentially included all 
patients who underwent Chartis measurement at our 
center during the given timeframe and did not leave pa-
tients out of the analysis. In addition, we were able to in-
clude a large number of measurements compared to oth-
er retrospective studies investigating Chartis [14, 19]. 
Furthermore, all measurements were performed in one 
specialized treatment center with only two physicians 
performing the measurements, leading to a high level of 
standardization. 
In conclusion, in this retrospective study we observed 
a significantly longer duration of the Chartis measure-
ment as well as a higher number of attempts needed un-
der conscious sedation compared to general anesthesia. 
This could indicate that the feasibility of the Chartis mea-
surement is better under general anesthesia. The results 
of this study suggest advantages of performing Chartis 
measurement under general anesthesia, without losing 
diagnostic power. We recommend performing a prospec-
tive trial comparing both techniques within the same pa-
tients to validate this approach.
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